Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
BRILACIDIN TETRAHYDROCHLORIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BRILACIDIN TETRAHYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
CM3HYX69SK
Molecule Type:
Small molecule
Molecular Formula:
C40H54Cl4F6N14O6
Molecular Weight:
1082.76
AlogP:
3.68
PSA:
308.5
HBD:
12.0
HBA:
#RotB:
20.0
Source:
FADOLMIDINE HYDROCHLORIDE
(2)
Small molecule
Adrenergic receptor alpha-2 agonist
Unknown
Investigational
Unknown
FADOLMIDINE HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
S3709T25V6
Molecule Type:
Small molecule
Molecular Formula:
C13H15ClN2O
Molecular Weight:
250.73
AlogP:
2.39
PSA:
48.91
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BMX-001
(2)
Small molecule
Metalloporphyrin antioxidant (antitumor, radioprotectant)
Unknown
Investigational
Unknown
BMX-001
×
Maximum Phase:
2
First Approval:
None
UNII:
MIJ02RO47F
Molecule Type:
Small molecule
Molecular Formula:
C64H76Cl5MnN8O4
Molecular Weight:
1253.57
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ADIPIPLON
(2)
Small molecule
GABA-A receptor; anion channel partial agonist
Unknown
Investigational
Unknown
ADIPIPLON
×
Maximum Phase:
2
First Approval:
None
UNII:
OPL214POJ1
Molecule Type:
Small molecule
Molecular Formula:
C18H18FN7
Molecular Weight:
351.39
AlogP:
2.83
PSA:
73.79
HBD:
0.0
HBA:
#RotB:
5.0
Source:
GSK163090
(2)
Small molecule
Serotonin 1a (5-HT1a) receptor antagonist
Unknown
Investigational
Unknown
GSK163090
×
Maximum Phase:
2
First Approval:
None
UNII:
7XI927X82B
Molecule Type:
Small molecule
Molecular Formula:
C25H29N5O
Molecular Weight:
415.54
AlogP:
3.44
PSA:
51.71
HBD:
1.0
HBA:
#RotB:
5.0
Source:
FISETIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
FISETIN
×
Maximum Phase:
2
First Approval:
None
UNII:
OO2ABO9578
Molecule Type:
Small molecule
Molecular Formula:
C15H10O6
Molecular Weight:
286.24
AlogP:
2.28
PSA:
111.13
HBD:
4.0
HBA:
#RotB:
1.0
Source:
CAVOSONSTAT
(2)
Small molecule
Alcohol dehydrogenase class III inhibitor
Unknown
Investigational
Unknown
CAVOSONSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
O2Z8Q22ZE4
Molecule Type:
Small molecule
Molecular Formula:
C16H10ClNO3
Molecular Weight:
299.71
AlogP:
3.96
PSA:
70.42
HBD:
2.0
HBA:
#RotB:
2.0
Source:
ULIXERTINIB
(2)
Small molecule
MAP kinase ERK1 inhibitor
Unknown
Investigational
Unknown
ULIXERTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
16ZDH50O1U
Molecule Type:
Small molecule
Molecular Formula:
C21H22Cl2N4O2
Molecular Weight:
433.34
AlogP:
4.67
PSA:
90.04
HBD:
4.0
HBA:
#RotB:
7.0
Source:
RALIMETINIB
(2)
Small molecule
MAP kinase p38 alpha inhibitor
Unknown
Investigational
Unknown
RALIMETINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
73I34XW4HD
Molecule Type:
Small molecule
Molecular Formula:
C24H29FN6
Molecular Weight:
420.54
AlogP:
5.55
PSA:
85.41
HBD:
2.0
HBA:
#RotB:
3.0
Source:
S-1360
(2)
Small molecule
Human immunodeficiency virus type 1 integrase inhibitor
Unknown
Investigational
Unknown
S-1360
×
Maximum Phase:
2
First Approval:
None
UNII:
W7KQU075CV
Molecule Type:
Small molecule
Molecular Formula:
C16H12FN3O3
Molecular Weight:
313.29
AlogP:
2.91
PSA:
92.01
HBD:
2.0
HBA:
#RotB:
5.0
Source:
THYMIDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
THYMIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
VC2W18DGKR
Molecule Type:
Small molecule
Molecular Formula:
C10H14N2O5
Molecular Weight:
242.23
AlogP:
-1.51
PSA:
104.55
HBD:
3.0
HBA:
#RotB:
2.0
Source:
GSK-1292263
(2)
Small molecule
Glucose-dependent insulinotropic receptor agonist
Unknown
Investigational
Unknown
GSK-1292263
×
Maximum Phase:
2
First Approval:
None
UNII:
R1J57STA6O
Molecule Type:
Small molecule
Molecular Formula:
C23H28N4O4S
Molecular Weight:
456.57
AlogP:
3.95
PSA:
98.42
HBD:
0.0
HBA:
#RotB:
7.0
Source:
ACEBILUSTAT
(2)
Small molecule
Leukotriene A4 hydrolase inhibitor
Unknown
Investigational
Unknown
ACEBILUSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
J64RI4D29U
Molecule Type:
Small molecule
Molecular Formula:
C29H27N3O4
Molecular Weight:
481.55
AlogP:
5.29
PSA:
79.04
HBD:
1.0
HBA:
#RotB:
8.0
Source:
3,5-DIIODOTHYROPROPIONIC ACID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
3,5-DIIODOTHYROPROPIONIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
1HTO2X0SJ9
Molecule Type:
Small molecule
Molecular Formula:
C15H12I2O4
Molecular Weight:
510.07
AlogP:
4.41
PSA:
66.76
HBD:
2.0
HBA:
#RotB:
5.0
Source:
MIRAMISTIN ION
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
MIRAMISTIN ION
×
Maximum Phase:
2
First Approval:
None
UNII:
62S6VPY15U
Molecule Type:
Small molecule
Molecular Formula:
C26H47N2O+
Molecular Weight:
403.68
AlogP:
6.47
PSA:
29.1
HBD:
1.0
HBA:
#RotB:
18.0
Source:
SULCARDINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
SULCARDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
4Q5HLV8HG1
Molecule Type:
Small molecule
Molecular Formula:
C24H33N3O4S
Molecular Weight:
459.61
AlogP:
3.07
PSA:
82.11
HBD:
2.0
HBA:
#RotB:
9.0
Source:
BATOPROTAFIB
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BATOPROTAFIB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOSDAGROCORAT
(2)
Small molecule
Glucocorticoid receptor modulator
Unknown
Investigational
Unknown
FOSDAGROCORAT
×
Maximum Phase:
2
First Approval:
None
UNII:
HPI19004QS
Molecule Type:
Small molecule
Molecular Formula:
C29H30F3N2O5P
Molecular Weight:
574.54
AlogP:
6.28
PSA:
108.75
HBD:
3.0
HBA:
#RotB:
6.0
Source:
TRIDECANOATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TRIDECANOATE
×
Maximum Phase:
2
First Approval:
None
UNII:
19936LIY2V
Molecule Type:
Small molecule
Molecular Formula:
C13H26O2
Molecular Weight:
214.35
AlogP:
4.38
PSA:
37.3
HBD:
1.0
HBA:
#RotB:
11.0
Source:
BRANEBRUTINIB
(2)
Small molecule
Tyrosine-protein kinase BTK inhibitor
Unknown
Investigational
Unknown
BRANEBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
7LBRZUYSHU
Molecule Type:
Small molecule
Molecular Formula:
C20H23FN4O2
Molecular Weight:
370.43
AlogP:
2.13
PSA:
91.22
HBD:
3.0
HBA:
#RotB:
3.0
Source:
INCB-40093
(2)
Small molecule
PI3-kinase p110-delta subunit inhibitor
Unknown
Investigational
Unknown
INCB-40093
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
.ALPHA.-R-LIPOIC ACID CHOLINE ESTER CHLORIDE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
.ALPHA.-R-LIPOIC ACID CHOLINE ESTER CHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
6HBG94710Z
Molecule Type:
Small molecule
Molecular Formula:
C13H26ClNO2S2
Molecular Weight:
327.94
AlogP:
2.95
PSA:
26.3
HBD:
0.0
HBA:
#RotB:
8.0
Source:
LANIQUIDAR
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LANIQUIDAR
×
Maximum Phase:
2
First Approval:
None
UNII:
K3FRN4DDOY
Molecule Type:
Small molecule
Molecular Formula:
C37H36N4O3
Molecular Weight:
584.72
AlogP:
6.49
PSA:
69.48
HBD:
0.0
HBA:
#RotB:
7.0
Source:
BRADANICLINE
(2)
Small molecule
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
Unknown
Investigational
Unknown
BRADANICLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
UM3821998K
Molecule Type:
Small molecule
Molecular Formula:
C22H23N3O2
Molecular Weight:
361.45
AlogP:
3.26
PSA:
58.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ALLANTOIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ALLANTOIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DEFERITAZOLE MAGNESIUM
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DEFERITAZOLE MAGNESIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
BG3Q8O5L5B
Molecule Type:
Small molecule
Molecular Formula:
C18H25MgNO8S
Molecular Weight:
439.77
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
FAXELADOL
(2)
Small molecule
Mu opioid receptor agonist
Unknown
Investigational
Unknown
FAXELADOL
×
Maximum Phase:
2
First Approval:
None
UNII:
C04V6SGK8H
Molecule Type:
Small molecule
Molecular Formula:
C15H23NO
Molecular Weight:
233.35
AlogP:
3.23
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
3.0
Source:
SODIUM GLYCIDIDAZOLE
(2)
Small molecule
Unknown
Unknown
Approved
Unknown
SODIUM GLYCIDIDAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
5YV419FIJS
Molecule Type:
Small molecule
Molecular Formula:
C18H22N7NaO10
Molecular Weight:
519.4
AlogP:
-0.31
PSA:
215.06
HBD:
1.0
HBA:
#RotB:
14.0
Source:
PREXASERTIB
(2)
Small molecule
Serine/threonine-protein kinase Chk1 inhibitor
Unknown
Investigational
Unknown
PREXASERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
820NH671E6
Molecule Type:
Small molecule
Molecular Formula:
C18H19N7O2
Molecular Weight:
365.4
AlogP:
2.22
PSA:
134.76
HBD:
3.0
HBA:
#RotB:
8.0
Source:
N,N-DIMETHYLTRYPTAMINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
N,N-DIMETHYLTRYPTAMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VANILLYL ALCOHOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VANILLYL ALCOHOL
×
Maximum Phase:
2
First Approval:
None
UNII:
X7EA1JUA6M
Molecule Type:
Small molecule
Molecular Formula:
C8H10O3
Molecular Weight:
154.16
AlogP:
0.89
PSA:
49.69
HBD:
2.0
HBA:
#RotB:
2.0
Source:
LUMINESPIB
(2)
Small molecule
Heat shock protein HSP90 inhibitor
Unknown
Investigational
Unknown
LUMINESPIB
×
Maximum Phase:
2
First Approval:
None
UNII:
C6V1DAR5EB
Molecule Type:
Small molecule
Molecular Formula:
C26H31N3O5
Molecular Weight:
465.55
AlogP:
4.13
PSA:
108.06
HBD:
3.0
HBA:
#RotB:
7.0
Source:
RIMIDUCID
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
RIMIDUCID
×
Maximum Phase:
2
First Approval:
None
UNII:
H564L1W5J2
Molecule Type:
Small molecule
Molecular Formula:
C78H98N4O20
Molecular Weight:
1411.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
TANZISERTIB
(2)
Small molecule
c-Jun N-terminal kinase 1 inhibitor
Unknown
Investigational
Unknown
TANZISERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
M5O06306UO
Molecule Type:
Small molecule
Molecular Formula:
C21H23F3N6O2
Molecular Weight:
448.45
AlogP:
3.66
PSA:
97.12
HBD:
3.0
HBA:
#RotB:
5.0
Source:
CICLETANINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
CICLETANINE
×
Maximum Phase:
2
First Approval:
None
UNII:
CHG7QC509W
Molecule Type:
Small molecule
Molecular Formula:
C14H12ClNO2
Molecular Weight:
261.71
AlogP:
3.37
PSA:
42.35
HBD:
1.0
HBA:
#RotB:
1.0
Source:
DS-1001B
(2)
Small molecule
Isocitrate dehydrogenase [NADP] cytoplasmic inhibitor
Unknown
Investigational
Unknown
DS-1001B
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C29H29Cl3FN3O4
Molecular Weight:
608.93
AlogP:
7.56
PSA:
85.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
1
2
…
125
126
127
128
129
130
131
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA